Selected research
Industry Research
Hemorrhoid Cream and Injector Industry Research Report 2026
Market perspective
The global Hemorrhoid Cream and Injector market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hemorrhoid Cream and Injector is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hemorrhoid Cream and Injector is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hemorrhoid Cream and Injector include Yunnan Baiyao Group, Xiuzheng Pharmaceutical Group, Takeda Pharmaceutical, Mayinglong Pharmaceutical Group, Tucks, Sun Pharma, Prestige Consumer Healthcare, Naticura and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hemorrhoid Cream and Injector market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemorrhoid Cream and Injector Market by Company
Yunnan Baiyao Group
Xiuzheng Pharmaceutical Group
Takeda Pharmaceutical
Mayinglong Pharmaceutical Group
Tucks
Sun Pharma
Prestige Consumer Healthcare
Naticura
Medline Industries
Ferndale Healthcare
eXroid
Doctor Bulter’s
Church and Dwight
Bausch Health
AdvaCare Pharma
Hemorrhoid Cream and Injector Segment by Type
Prescription Drug
Over-The-Counter Drug
Hemorrhoid Cream and Injector Segment by Application
Hospital
Household Use
Others
Hemorrhoid Cream and Injector Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhoid Cream and Injector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemorrhoid Cream and Injector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhoid Cream and Injector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemorrhoid Cream and Injector manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemorrhoid Cream and Injector by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemorrhoid Cream and Injector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drug
- Over-The-Counter Drug
Applications
- Hospital
- Household Use
- Others
Companies covered
- Yunnan Baiyao Group
- Xiuzheng Pharmaceutical Group
- Takeda Pharmaceutical
- Mayinglong Pharmaceutical Group
- Tucks
- Sun Pharma
- Prestige Consumer Healthcare
- Naticura
- Medline Industries
- Ferndale Healthcare
- eXroid
- Doctor Bulter’s
- Church and Dwight
- Bausch Health
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemorrhoid Cream and Injector Market Size (2021-2032)
- 2.2.2 Global Hemorrhoid Cream and Injector Sales (2021-2032)
- 2.2.3 Global Hemorrhoid Cream and Injector Market Average Price (2021-2032)
- 2.3 Hemorrhoid Cream and Injector by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Prescription Drug
- 2.3.3 Over-The-Counter Drug
- 2.4 Hemorrhoid Cream and Injector by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Household Use
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemorrhoid Cream and Injector Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemorrhoid Cream and Injector Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hemorrhoid Cream and Injector Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemorrhoid Cream and Injector Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemorrhoid Cream and Injector Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemorrhoid Cream and Injector, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemorrhoid Cream and Injector, Product Type & Application
- 3.8 Global Manufacturers of Hemorrhoid Cream and Injector, Established Date
- 3.9 Global Hemorrhoid Cream and Injector Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yunnan Baiyao Group
- 4.1.1 Yunnan Baiyao Group Company Information
- 4.1.2 Yunnan Baiyao Group Business Overview
- 4.1.3 Yunnan Baiyao Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yunnan Baiyao Group Hemorrhoid Cream and Injector Product Portfolio
- 4.1.5 Yunnan Baiyao Group Recent Developments
- 4.2 Xiuzheng Pharmaceutical Group
- 4.2.1 Xiuzheng Pharmaceutical Group Company Information
- 4.2.2 Xiuzheng Pharmaceutical Group Business Overview
- 4.2.3 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
- 4.2.5 Xiuzheng Pharmaceutical Group Recent Developments
- 4.3 Takeda Pharmaceutical
- 4.3.1 Takeda Pharmaceutical Company Information
- 4.3.2 Takeda Pharmaceutical Business Overview
- 4.3.3 Takeda Pharmaceutical Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Takeda Pharmaceutical Hemorrhoid Cream and Injector Product Portfolio
- 4.3.5 Takeda Pharmaceutical Recent Developments
- 4.4 Mayinglong Pharmaceutical Group
- 4.4.1 Mayinglong Pharmaceutical Group Company Information
- 4.4.2 Mayinglong Pharmaceutical Group Business Overview
- 4.4.3 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
- 4.4.5 Mayinglong Pharmaceutical Group Recent Developments
- 4.5 Tucks
- 4.5.1 Tucks Company Information
- 4.5.2 Tucks Business Overview
- 4.5.3 Tucks Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tucks Hemorrhoid Cream and Injector Product Portfolio
- 4.5.5 Tucks Recent Developments
- 4.6 Sun Pharma
- 4.6.1 Sun Pharma Company Information
- 4.6.2 Sun Pharma Business Overview
- 4.6.3 Sun Pharma Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharma Hemorrhoid Cream and Injector Product Portfolio
- 4.6.5 Sun Pharma Recent Developments
- 4.7 Prestige Consumer Healthcare
- 4.7.1 Prestige Consumer Healthcare Company Information
- 4.7.2 Prestige Consumer Healthcare Business Overview
- 4.7.3 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Product Portfolio
- 4.7.5 Prestige Consumer Healthcare Recent Developments
- 4.8 Naticura
- 4.8.1 Naticura Company Information
- 4.8.2 Naticura Business Overview
- 4.8.3 Naticura Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Naticura Hemorrhoid Cream and Injector Product Portfolio
- 4.8.5 Naticura Recent Developments
- 4.9 Medline Industries
- 4.9.1 Medline Industries Company Information
- 4.9.2 Medline Industries Business Overview
- 4.9.3 Medline Industries Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Medline Industries Hemorrhoid Cream and Injector Product Portfolio
- 4.9.5 Medline Industries Recent Developments
- 4.10 Ferndale Healthcare
- 4.10.1 Ferndale Healthcare Company Information
- 4.10.2 Ferndale Healthcare Business Overview
- 4.10.3 Ferndale Healthcare Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ferndale Healthcare Hemorrhoid Cream and Injector Product Portfolio
- 4.10.5 Ferndale Healthcare Recent Developments
- 4.11 eXroid
- 4.11.1 eXroid Company Information
- 4.11.2 eXroid Business Overview
- 4.11.3 eXroid Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 eXroid Hemorrhoid Cream and Injector Product Portfolio
- 4.11.5 eXroid Recent Developments
- 4.12 Doctor Bulter’s
- 4.12.1 Doctor Bulter’s Company Information
- 4.12.2 Doctor Bulter’s Business Overview
- 4.12.3 Doctor Bulter’s Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Doctor Bulter’s Hemorrhoid Cream and Injector Product Portfolio
- 4.12.5 Doctor Bulter’s Recent Developments
- 4.13 Church and Dwight
- 4.13.1 Church and Dwight Company Information
- 4.13.2 Church and Dwight Business Overview
- 4.13.3 Church and Dwight Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Church and Dwight Hemorrhoid Cream and Injector Product Portfolio
- 4.13.5 Church and Dwight Recent Developments
- 4.14 Bausch Health
- 4.14.1 Bausch Health Company Information
- 4.14.2 Bausch Health Business Overview
- 4.14.3 Bausch Health Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bausch Health Hemorrhoid Cream and Injector Product Portfolio
- 4.14.5 Bausch Health Recent Developments
- 4.15 AdvaCare Pharma
- 4.15.1 AdvaCare Pharma Company Information
- 4.15.2 AdvaCare Pharma Business Overview
- 4.15.3 AdvaCare Pharma Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 AdvaCare Pharma Hemorrhoid Cream and Injector Product Portfolio
- 4.15.5 AdvaCare Pharma Recent Developments
5 Global Hemorrhoid Cream and Injector Market Scenario by Region
- 5.1 Global Hemorrhoid Cream and Injector Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemorrhoid Cream and Injector Sales by Region: 2021-2032
- 5.2.1 Global Hemorrhoid Cream and Injector Sales by Region: 2021-2026
- 5.2.2 Global Hemorrhoid Cream and Injector Sales by Region: 2027-2032
- 5.3 Global Hemorrhoid Cream and Injector Revenue by Region: 2021-2032
- 5.3.1 Global Hemorrhoid Cream and Injector Revenue by Region: 2021-2026
- 5.3.2 Global Hemorrhoid Cream and Injector Revenue by Region: 2027-2032
- 5.4 North America Hemorrhoid Cream and Injector Market Facts & Figures by Country
- 5.4.1 North America Hemorrhoid Cream and Injector Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemorrhoid Cream and Injector Sales by Country (2021-2032)
- 5.4.3 North America Hemorrhoid Cream and Injector Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemorrhoid Cream and Injector Market Facts & Figures by Country
- 5.5.1 Europe Hemorrhoid Cream and Injector Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemorrhoid Cream and Injector Sales by Country (2021-2032)
- 5.5.3 Europe Hemorrhoid Cream and Injector Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemorrhoid Cream and Injector Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemorrhoid Cream and Injector Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemorrhoid Cream and Injector Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemorrhoid Cream and Injector Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemorrhoid Cream and Injector Market Facts & Figures by Country
- 5.7.1 South America Hemorrhoid Cream and Injector Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemorrhoid Cream and Injector Sales by Country (2021-2032)
- 5.7.3 South America Hemorrhoid Cream and Injector Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemorrhoid Cream and Injector Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemorrhoid Cream and Injector Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemorrhoid Cream and Injector Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemorrhoid Cream and Injector Sales by Type (2021-2032)
- 6.1.1 Global Hemorrhoid Cream and Injector Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hemorrhoid Cream and Injector Sales Market Share by Type (2021-2032)
- 6.2 Global Hemorrhoid Cream and Injector Revenue by Type (2021-2032)
- 6.2.1 Global Hemorrhoid Cream and Injector Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemorrhoid Cream and Injector Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemorrhoid Cream and Injector Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemorrhoid Cream and Injector Sales by Application (2021-2032)
- 7.1.1 Global Hemorrhoid Cream and Injector Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hemorrhoid Cream and Injector Sales Market Share by Application (2021-2032)
- 7.2 Global Hemorrhoid Cream and Injector Revenue by Application (2021-2032)
- 7.2.1 Global Hemorrhoid Cream and Injector Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemorrhoid Cream and Injector Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemorrhoid Cream and Injector Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemorrhoid Cream and Injector Value Chain Analysis
- 8.1.1 Hemorrhoid Cream and Injector Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemorrhoid Cream and Injector Production Mode & Process
- 8.2 Hemorrhoid Cream and Injector Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemorrhoid Cream and Injector Distributors
- 8.2.3 Hemorrhoid Cream and Injector Customers
9 Global Hemorrhoid Cream and Injector Analyzing Market Dynamics
- 9.1 Hemorrhoid Cream and Injector Industry Trends
- 9.2 Hemorrhoid Cream and Injector Industry Drivers
- 9.3 Hemorrhoid Cream and Injector Industry Opportunities and Challenges
- 9.4 Hemorrhoid Cream and Injector Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst